Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ZBIO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ZBIO investment potential.

What is ZBIO stock price today?

Get real-time ZBIO stock price, historical data, and price charts on Financhill. Track ZBIO performance with our advanced analysis tools.

Is ZBIO a good investment?

Evaluate ZBIO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ZBIO stock?

To buy ZBIO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ZBIO?

View detailed market capitalization data and company valuation metrics for ZBIO on our comprehensive analysis page.

What is the P/E ratio of ZBIO?

Use our fundamental analysis tools to view ZBIO P/E ratio and compare valuation metrics with industry peers.

What are ZBIO earnings?

View ZBIO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Zenas BioPharma, Inc. Stock Predictions

This Critical Mineral's Up 122% in the Last 12 Months.

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Sell

ZBIO
Zenas BioPharma, Inc.

Last Price:

$21.80

Seasonality Move:

-2.2%

7 Day Trial

ALL ACCESS PASS

$ 7

$10K Investment in Nvidia Could've Made $2.5M

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Zenas BioPharma, Inc. Stock Forecast

Over the next 52 weeks, Zenas BioPharma, Inc. has on average historically fallen by 1.2% based on the past 5 years of stock performance.
Zenas BioPharma, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Zenas BioPharma, Inc. Stock Undervalued?

The current Zenas BioPharma, Inc. [ZBIO] share price is $21.80. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Zenas BioPharma, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Zenas BioPharma, Inc. has on average historically fallen by 1.2% based on the past 5 years of stock performance.

Zenas BioPharma, Inc. Stock Rating

Sell

Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. overpriced?

Zenas BioPharma, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Zenas BioPharma, Inc. Stock Price History

Is ZBIO stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

zenasbio.com

52-Week Data

52-Week High:

44.60

52-Week Low:

6.11

Prediction Charts

Market Cap:

912M

Price in USD:

21.80

Volume:

864.3K

Beta:

-1.59

Technical Analysis

SMA50:

29.27

SMA100:

28.22

SMA200:

20.65

52-Wk Change:

177.71%

Stock Predictions

Is Zenas BioPharma, Inc. stock public?

Yes, Zenas BioPharma, Inc. is a publicly traded company.
What is the Zenas BioPharma, Inc. stock quote today?

The Zenas BioPharma, Inc. stock price is 21.80 USD today.
How to buy Zenas BioPharma, Inc. stock online?

You can buy Zenas BioPharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-20	19.76	20.88	21.01	19.20
Jan-21	20.87	19.59	21.39	19.40
Jan-22	19.68	20.40	20.78	19.49
Jan-23	20.29	20.09	20.52	19.55
Jan-26	19.80	19.32	19.84	19.00
Jan-27	19.32	20.07	20.11	19.15
Jan-28	19.97	21.47	21.60	19.30
Jan-29	21.05	20.88	22.70	20.42
Jan-30	20.64	18.37	21.17	18.24
Feb-2	18.33	18.15	18.72	17.60
Feb-3	18.34	19.72	20.08	18.00
Feb-4	21.21	20.66	22.28	20.54
Feb-5	20.25	21.01	21.64	19.21
Feb-6	21.48	21.80	22.43	20.91

Zenas BioPharma, Inc. Earnings

Zenas BioPharma, Inc. Earnings Report: Per Share Zenas BioPharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Zenas BioPharma, Inc. Forecast Revenue Growth

Zenas BioPharma, Inc. Stock Analysis: Historical quarterly revenues per share for Zenas BioPharma, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.22 per share.

* Zenas BioPharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.